Access and Co-pay Assistance - VYVGART Hytrulo
OpenVerified·Apr 24, 2026
- Covers
- financial assistance
- Max award
- $25,000
- Enrollment cycle
- rolling
Eligibility
Eligible patients must have commercial insurance and a valid prescription for an on-label indication of VYVGART or VYVGART Hytrulo. The program provides up to $25,000 per calendar year to cover out-of-pocket drug and administration costs.
Apply
Application goes directly to the program. RxCopays does not receive compensation.
Go to application →Status source
Your commercially insured patients could be eligible for a $0 co-pay through the VYVGART Co-pay Program*
Rare-disease support beyond financial help
This grant covers a rare condition. For specialists, clinical trials, and patient communities, our sister site UniteRare.org has in-depth pages: